Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zhizhen Biology is a Shanghai-based biotechnology company specializing in advanced molecular diagnostic solutions. The company focuses on the development of ultrafast PCR systems and microfluidic chip technologies to enable rapid, point-of-care testing for infectious diseases. Their product portfolio includes automated nucleic acid extraction systems, portable PCR instruments, and a wide range of detection kits for human health, animal disease, and food safety. By integrating microfluidics with molecular biology, Zhizhen Biology provides high-sensitivity diagnostic tools that are accessible outside of traditional laboratory settings. The company serves clinical, veterinary, and industrial markets with integrated instrument and reagent solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 上海致真生物.